Quantcast

Posts related to ‘Healthcare’

biotech

PropThink Biotech Stocks to Buy with Big Gains: Cubist, Immunomedics and More

Posted: May 23, 2013 at 8:25 am

The world of biotech investing is always a difficult one. Often a binary event, such as U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise, is the ...
Read Full Story »
Herbalife Logo

Herbalife Stock Halted Briefly as New Audit Firm Named

Posted: May 21, 2013 at 12:29 pm

Shares of Herbalife Ltd. (NYSE: HLF) were halted briefly shortly before noon today as we all waited breathlessly for news. When the new arrived, well, how exciting can a new ...
Read Full Story »
Sad lonely pensive old senior woman

States with the Most Americans on Disability

Posted: May 20, 2013 at 6:47 am

The number of Americans receiving Social Security Disability Insurance (SSDI) more-than doubled over the past two decades, from 5.2 million to 11.7 million by the end of 2011. The number ...
Read Full Story »
Food and Drug Administration logo

Dendreon Gets Prostate Cancer Competition for Provenge from Bayer’s Xofigo

Posted: May 15, 2013 at 11:15 am

Dendreon Corp. (NASDAQ: DNDN) has been facing problems getting its Provenge sales for advanced metastatic prostate cancer through to the market. Even a direct to consumer advertising campaign has so ...
Read Full Story »
pills

Deutsche Bank Firm on Biotech Stocks to Buy

Posted: May 15, 2013 at 8:10 am

Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the ...
Read Full Story »
biotech

Myriad Genetics, Angelina Jolie and Genomics in Focus

Posted: May 14, 2013 at 1:58 pm

Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic test using Myriad's gene sequencing tested positive for the ...
Read Full Story »
health care

Jefferies Stocks to Buy: Big Gains in Life Sciences and Diagnostics

Posted: May 13, 2013 at 8:00 am

In theory, medical technology companies should be some of the market’s best-performing stocks. After all, it’s not really a cyclical business, and price tags are rarely a stumbling block when ...
Read Full Story »
biotech

Dendreon Shows Poor Provenge Sales, Implosion Risk Rising

Posted: May 9, 2013 at 10:25 am

Dendreon Corp. (NASDAQ: DNDN) just cannot catch a break. Despite having what was supposed to be one of the best late-stage prostate treatments in Provenge, sales just are not coming ...
Read Full Story »
health care

Workers Taking the Most Sick Days

Posted: May 9, 2013 at 6:21 am

Sick days are estimated to cost the U.S. economy $84 billion each year. According to the latest data released in a joint study by Gallup and Healthways, some professions miss ...
Read Full Story »
health care

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

Posted: May 6, 2013 at 10:45 am

The world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States ...
Read Full Story »
Stock Split Image

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Posted: May 1, 2013 at 10:45 am

Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many ...
Read Full Story »
biotech

PropThink Analyst Finds Five Cheap Biotech Stocks to Buy

Posted: May 1, 2013 at 8:40 am

Biotech investing has always proven to be a slippery slope. It is one thing to own one of the large-cap biotech stocks, but it can be a challenge when looking for ...
Read Full Story »
Johnson & Johnson Logo

Better-Than-Expected DJIA Dividend Surprise from Johnson & Johnson

Posted: April 25, 2013 at 11:25 am

We have now seen three Dow Jones Industrial Average components raise their dividend payouts to shareholders this week. The third is Johnson & Johnson (NYSE: JNJ), which has just declared ...
Read Full Story »
76764023

Obesity and Weight Loss Drug Shipments Rising

Posted: April 19, 2013 at 9:10 am

VIVUS Inc. (NASDAQ: VVUS) is the king of weight loss drugs now that it is operating with the first pill to help assist weight loss in a decade. The company's ...
Read Full Story »
biotech

Merrill Lynch Offers Four Key Biotech Drug Updates

Posted: April 17, 2013 at 11:45 am

Biotech pipeline news and biotech drug news continues to hit. A report from Bank of America/Merrill Lynch is highlighting four small-cap to mid-cap biotech stocks with positive prescription trends so far ...
Read Full Story »